QED Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
QED Therapeutics, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TRUSELTIQ. The owner is based in San Francisco, CA.
75 Federal Street
San Francisco, CA 94017
Showing of trademarks Trademarks
Trademark Classifications
QED Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does QED Therapeutics, Inc. have?
QED Therapeutics, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned.
What trademark classes does QED Therapeutics, Inc. file in?
QED Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are QED Therapeutics, Inc.'s most well-known trademarks?
QED Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as TRUSELTIQ. These are among 1 currently registered trademark in the portfolio.
What is QED Therapeutics, Inc.'s trademark registration success rate?
QED Therapeutics, Inc. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.